These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3310925)

  • 21. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
    Kim WU; Cho ML; Kim SI; Yoo WH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Feb; 27(2):324-31. PubMed ID: 10685792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balancing effectiveness and toxicity of levamisole in the treatment of rheumatoid arthritis.
    Runge LA; Rynes RI
    Clin Exp Rheumatol; 1983; 1(2):125-31. PubMed ID: 6398156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
    Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo.
    Woodland J; Chaput de Saintonge DM; Evans SJ; Sharman VL; Currey HL
    Ann Rheum Dis; 1981 Aug; 40(4):355-9. PubMed ID: 7020612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell stimulator undergoes diverse testing.
    Gunby P
    JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781
    [No Abstract]   [Full Text] [Related]  

  • 28. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
    Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
    J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.
    Amalraj A; Varma K; Jacob J; Divya C; Kunnumakkara AB; Stohs SJ; Gopi S
    J Med Food; 2017 Oct; 20(10):1022-1030. PubMed ID: 28850308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis.
    Huizinga TW; Batalov A; Stoilov R; Lloyd E; Wagner T; Saurigny D; Souberbielle B; Esfandiari E
    Arthritis Res Ther; 2017 Mar; 19(1):53. PubMed ID: 28274253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, cross-over, international multicentre investigation of two doses of indoprofen compared with ASA and placebo in rheumatoid arthritis.
    Kolarz G
    Eur J Rheumatol Inflamm; 1981; 4(1):53-9. PubMed ID: 7042362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
    Barnett ML; Kremer JM; St Clair EW; Clegg DO; Furst D; Weisman M; Fletcher MJ; Chasan-Taber S; Finger E; Morales A; Le CH; Trentham DE
    Arthritis Rheum; 1998 Feb; 41(2):290-7. PubMed ID: 9485087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study.
    Genovese MC; Van den Bosch F; Roberson SA; Bojin S; Biagini IM; Ryan P; Sloan-Lancaster J
    Arthritis Rheum; 2010 Apr; 62(4):929-39. PubMed ID: 20131262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM
    Bone Marrow Transplant; 1998 Dec; 22(11):1035-41. PubMed ID: 9877264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate.
    Genovese MC; Lee E; Satterwhite J; Veenhuizen M; Disch D; Berclaz PY; Myers S; Sides G; Benichou O
    Ann Rheum Dis; 2013 Sep; 72(9):1453-60. PubMed ID: 23599435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study.
    Brackertz D; Vischer TL
    J Rheumatol; 1989 Jan; 16(1):19-23. PubMed ID: 2654391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibuprofen and diflunisal in rheumatoid arthritis: a double-blind comparative trial.
    Palmer DG; Ferry DG; Gibbins BL; Hall SM; Grennan DM; Lum J; Myers DB
    N Z Med J; 1981 Jul; 94(688):45-7. PubMed ID: 7024866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term, double-blind, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis.
    Bröll H
    Eur J Rheumatol Inflamm; 1981; 4(1):126-34. PubMed ID: 7042356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis.
    Shiokawa Y; Horiuchi Y; Mizushima Y; Kageyama T; Shichikawa K; Ofuji T; Honma M; Yoshizawa H; Abe C; Ogawa N
    J Rheumatol; 1984 Oct; 11(5):615-23. PubMed ID: 6392550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.